Generics 23

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Sunitinib manufacturers

23 products found

Filters

23 products found

sunitinib

Capsules 12.5mg; 25mg; 37.5mg; 50mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
FDA, EU GMP
Unavailable markets
Egypt , Lebanon , Algeria , Bahrain , Kuwait , Oman , Qatar , Saudi Arabia , United Arab Emirates , Libya , Paraguay , Sudan , Iraq , Pakistan , Vietnam , Jordan , Costa Rica , Belize , El Salvador , Guatemala , Honduras , Nicaragua , Panama , Bahamas , Trinidad And Tobago , Cuba , Jamaica , Dominican Republic , Haiti , Barbados , Turks And Caicos Islands , Saint Lucia , Grenada , Cayman Islands , Dominica , U.S. Virgin Islands , Mexico , Colombia , Guyana , Venezuela
Manufacturer #8191
A pharmaceutical manufacturer based in Europe that has been active in 10+ countries selling its products in Europe, North America, Asia, MENA, and LATAM for 10+ years. The main therapeutic areas include oncology and immunology. The company's production lines are GMP-compliant. The company possesses branches in Europe and MENA.

Manufacturer usually replies in 9 days

sunitinib

Capsules 12.5 mg, 25 mg, 37.5 mg, 50 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #614
A pharmaceutical manufacturer based in Europe selling its products in Europe and worldwide for 10+ years. Main dosage forms include injectable and oral dosage forms. The company's production lines are EU GMP-compliant. The main therapeutic area is oncology.

Manufacturer usually replies in 7 days

sunitinib

Capsules 12,5; 25; 50 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #11542
It is one of the most rapidly expanding pharmaceutical enterprises in Europe. A cutting-edge pharmaceutical manufacturing plant and a laboratory with the highest-quality equipment are among the manufacturing facilities. The production lines and laboratories follow European standards, and a team of competent personnel ensures that these guidelines are followed. The manufacturing procedures meet all GMP regulations, whereas clinical trial goods are made per GLP and GMP principles.

Manufacturer usually replies in 9 days

sunitinib

Capsules 12.5 mg, 25 mg, 37.5 mg, 50 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #519

Manufacturer usually replies in 6 days

sunitinib

Capsules 12.5 mg, 25 mg, 37.5 mg, 50 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
FDA, EU GMP, ANVISA, Libya, Saudi Arabia, South Korea
Unavailable markets
Iran , Iraq , Egypt , Kuwait , Qatar , Bahrain , Algeria , Djibouti , Israel , Jordan , Lebanon , Libya , Malta , Morocco , Oman , Saudi Arabia , Syria , Tunisia , United Arab Emirates , Yemen , Ethiopia , Sudan , Vietnam
Manufacturer #11907
A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products for 20+ years. Key production lines include Rx, OTC, medical devices, and cosmetics. The company's production lines are EU GMP-compliant. The company owns branches in the EU, North America, and Africa.

Manufacturer usually replies in 8 days

sunitinib

Capsules, hard liquid 12.5 mg, 25 mg, 37.5 mg, 50 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #21467

Manufacturer usually replies in 10 days

sunitinib

Capsules 12.5 mg, 25 mg, 37.5 mg, 50 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #15070

A pharmaceutical manufacturer based in the EU that is selling its products in EU, CIS, and Asia. Key production lines are Rx, OTC, medical devices, and nutraceuticals. The company's production lines are EU GMP-compliant.

Manufacturer usually replies in 8 days

sunitinib

Capsules 12.5 mg, 25 mg, 37.5 mg, 50 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq , Vietnam
Available for
Licensing with supply, Technology transfer
Manufacturer #260
Pharmaceutical manufacturer operating in the EU for 50+ years. Activities include scientific development, manufacturing, out-licensing, marketing, and distribution of high-quality generic medicines. The company owns several production facilities that all comply with EU GMP requirements. Key dosage forms include conventional solids, cytostatic injectables, and cytostatic orals. The company holds an in-house R&D and Intellectual property business unit, as well as a regulatory affairs team that prepares CTD dossiers and maintains direct contact with regulatory agencies worldwide. The portfolio includes more than three thousand MA sets approved in the EU while hundreds of MA are in progress. Key therapy lines are cardiovascular, CNS, diabetes, immunology, oncology, and more. The company is active in nearly 100 countries worldwide, selling its products in Africa, Asia, Australia, Europe, LATAM, and the Middle East.

Manufacturer usually replies in 12 days

sunitinib

Capsules 12.5 mg, 25 mg, 37.5 mg, 50 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Portugal , Vietnam
Manufacturer #437
A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products in Europe, North America, LATAM, Africa, Middle East, and Asia for 40+ years. Main therapeutics areas include the nervous system, cardiometabolic, and women’s health. The company's production lines are GMP-compliant. The main dosage forms are solid, semi-solid, liquid, and suspension. The company owns branches in the EU, Africa, and LATAM.

Manufacturer usually replies in 11 days

sunitinib

Capsules 12.5 mg, 25 mg, 37.5 mg, 50 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Available for
Licensing with supply
Comments
Indication: Kidney Cancer; Status: MA granted
Manufacturer #385

A pharmaceutical manufacturer based in the EU that has been active in 60+ countries selling its products in Europe, North America, LATAM, MENA, Africa, and Asia for 60+ years. Key production lines are Rx and nutraceuticals. The company's production lines are EU GMP-compliant.

Manufacturer usually replies in 11 days

sunitinib

Capsules Upon request

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #10033
A pharmaceutical manufacturer based in Europe specializes in development and manufacturing for 10+ years. Key production lines are Rx, OTC, and nutraceuticals. The main therapy areas include the immune system, CNS, and cardiovascular system. The main dosage forms include solid oral and injectable.

Manufacturer usually replies in 11 days

sunitinib

Capsules 12.5 mg, 25 mg, 37.5 mg, 50 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP, ANVISA
Unavailable markets
Vietnam
Registered in
Portugal
Available for
Licensing with supply
Manufacturer #358
A pharmaceutical manufacturer based in the EU that is active in 70+ countries worldwide selling its products in the EU, Australia, Pacific region, and Asia for 30+ years. The company owns several manufacturing plants that comply with EU GMP requirements with production facilities for Rx products, OTC products, nutraceuticals, and medical devices. Its key therapy areas are diabetology, oncology, and neuropsychiatry. The company possesses several R&D centers with hundreds of patents and provides e-CTD format dossiers.

Manufacturer usually replies in 23 days

sunitinib

Capsules 12.5 mg, 25 mg, 37.5 mg, 50 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
MAs for sale
Luxembourg , Netherlands , Portugal
Manufacturer #276

Manufacturer usually replies in nan days

sunitinib

Capsules 12.5 mg, 25 mg, 37.5 mg, 50 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
Costa Rica
Manufacturer #1338

Manufacturer usually replies in 7 days

sunitinib

Capsules 12.5 mg, 25 mg, 50 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
Turkey
GMP approvals
EU GMP
Unavailable markets
Bulgaria , Costa Rica , Vietnam
Registered in
Turkey
Manufacturer #361
It is a global player with more than half a century of experience. It has more than 4 facilities to operate from. They have marketing and promotion in more than 20 countries. It exports to more than 50 countries. The only motto is to improve the quality of human life and to provide access to reliable, high-quality products for human health worldwide. It is focused to create its own cadres in every country it operates.

Manufacturer usually replies in 9 days

sunitinib

Capsules 12.5 mg, 25 mg, 37.5 mg , 50 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
Chile , Turkey , Vietnam , Panama
Available for
Licensing with supply
Manufacturer #261
A pharmaceutical manufacturer based in the EU that has been selling its products in Europe for 20+ years. Main therapeutic areas include diabetes, CNL, dermatology, and oncology. Main dosage forms include solid and liquid oral, sterile dosage forms, and ointments. The company possesses 10+ manufacturing facilities that are cGMP-compliant.

Manufacturer usually replies in 6 days

sunitinib

Capsules 12.5 mg, 25 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #9406

Manufacturer usually replies in 7 days

sunitinib

Capsules 12.5 mg, 25 mg, 37.5 mg, 50 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
Turkey
GMP approvals
EU GMP
Manufacturer #2722
It originally entered the pharmaceutical industry in 1987, when it introduced blood derivative products to Europe and became the exclusive distributor for prominent European brands. Oncology, hematology, dermatology, radiology, rheumatology, immunology, and OTC products are the seven main therapeutic fields.

Manufacturer usually replies in 6 days

sunitinib

Capsules 25 mg, 50 mg, 125 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18530

Manufacturer usually replies in 4 days

sunitinib

Tablets 25 mg, 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19670

Manufacturer usually replies in 8 days

Want to view all 23 products? Create your free account today!

Sunitinib Manufacturers

Sunitinib is a cancer medication used to treat renal cell carcinoma, pancreatic cancer, kidney cancer, and imatinib-resistant gastrointestinal stromal tumor. It is marketed in 12.5mg, 25mg, and 50mg sunitinib oral capsule form. In most markets, the only sunitinib drug available is Sutent, produced by manufacturer CPPI CV (a subsidiary of Pfizer). First granted marketing authorization from the FDA in 2006, Sutent is now approved in and distributed to over 110 countries and has been used for the treatment of over 350,000 patients worldwide. Since its release, it has become a popular pharmaceutical choice across all of its indications, in spite of pressure for substitute medications, such as pazopanib (marketed as Votrient by supplier Novartis), and axitinib (marketed as Inlyta by supplier Pfizer). Supplier Pfizer maintains market exclusivity for sunitinib in many markets, with patents set to expire in the U.S. and Europe only 2021. In some countries, however, manufacturer and supplier Teva pharma have managed to obtain approval to market a generic version of sunitinib. Due to high costs associated with the manufacturing process, sunitinib can be regarded and has reportedly been criticized for being, a very expensive medication.

How Does Sunitinib Work?

Sunitinib inhibits a variety of RTKs, some of which are connected to the development of tumours, pathologic angiogenesis, and the spread of cancer through metastasis. Platelet-derived growth factor receptors, vascular endothelial growth factor receptors, stem cell factor receptor, Fms-like tyrosine kinase-3 colony arousing factor receptor type 1, and the glial cell-line sourced neurotrophic factor receptor were all found to be targets of sunitinib's inhibitory activity against a variety of kinases. Biochemical and cellular experiments have shown that sunitinib inhibits the activity of several RTKs, and cell proliferation assays have shown that sunitinib inhibits function. In molecular and physiological studies, the main metabolite shows comparable potency to sunitinib.

Wholesale Price of Sunitinib

The EU retail prices of the drug are approximately 1050-1100 EUR for 28 12.5mg sunitinib capsules, and 4200-4250 EUR for the same amount of 50mg capsules. That being said, generic sunitinib can cost up to two times less. Sunitinib is available for sale from various Sunitinib vendors at multiple costs. The price of Sunitinib is higher than that of such substitutes, owing largely to the more costly manufacturing process needed to produce it. Also, the costs of Sunitinib vary depending on manufacturer and supplier pricing, whether it is a generic or trade name formulation, concentration of the active ingredient in the formulation. It is available or sale at every medical store. Sunitinib suppliers, on the whole, are in favor of patient aid initiatives.

From Where to Get Sunitinib?

Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified Sunitinib manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. Buyers are advised to buy from PipelinePharma. Making use of Pipelinepharma's worldwide B2B online marketplace for medications and other pharmaceuticals is the ideal approach to locate and acquire access to Sunitinib manufacturers and suppliers. Finding reliable suppliers and manufacturers of particular medications like Sunitinib can typically be a time-consuming challenge, but with Pipelinepharma's straightforward search engine and network of tested partners, the entire process becomes much simpler. Utilizing our built-in search engine, all you have to do to begin going is start looking for potential Sunitinib suppliers or manufacturers. You may also use filters to narrow down your search results and look for Sunitinib from particular nations.

Navigating our Pharmaceutical Marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Sunitinib offerings can be narrowed down with filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for this substance manufacturer and Sunitinib suppliers that you are looking for. These also enable you to check the dossier status of this medicine and the GMP approvals of the different variants of Sunitinib. Also, each manufacturer or supplier product description contains essential information about this substance, including clinical data, stability zones, and countries in which Sunitinib is already registered. Manufacturers also have special delivery terms.

Establishing Commercial Ties

Suppose you are a pharmaceutical licensing company or a distributor. In that case, you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and order process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the Sunitinib suppliers. This way, the marketplace allows you as a distributor to skip the process of making a list of product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are boarded on the platform. This allows us to screen Sunitinib manufacturers for the quality of the pharmaceutical products' dossiers and protect against the risk of possible malpractices.